Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
Albuminuria as a marker of systemic congestion in patients with heart failure( )
Boorsma, E. M., Ter Maaten, J. M., Damman, K., van Essen, B. J., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Dickstein, K., Metra, M., Filippatos, G., Lang, C. C., Ng, L., Anker, S. D., Cleland, J. G., Pellicori, P., Gansevoort, R. T., Heerspink, H. J. L., Voors, A. A. & Emmens, J. E., 1-feb.-2023, In: European Heart Journal. 44, 5, blz. 368-380 13 blz., ehac528.Onderzoeksoutput › Academic › peer review
Open AccessBestand6 Citaten (Scopus)14 Downloads (Pure) -
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
Schnell, O., Battelino, T., Bergenstal, R., Birkenfeld, A. L., Ceriello, A., Cheng, A., Davies, M., Edelman, S., Forst, T., Giorgino, F., Green, J., Groop, P. H., Hadjadj, S., J.L.Heerspink, H., Hompesch, M., Izthak, B., Ji, L., Kanumilli, N., Mankovsky, B., Mathieu, C., & 16 anderen, 2023, In: Cardiovascular Diabetology. 22, 1, 12 blz., 59.Onderzoeksoutput › Academic › peer review
Open AccessBestand6 Downloads (Pure) -
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)
Green, J. B., Mottl, A. K., Bakris, G., Heerspink, H. J. L., Mann, J. F. E., McGill, J. B., Nangaku, M., Rossing, P., Scott, C., Gay, A. & Agarwal, R., apr.-2023, In: Nephrology Dialysis Transplantation. 38, 4, 10 blz., gfac198.Onderzoeksoutput › Academic › peer review
Open AccessBestand24 Citaten (Scopus)150 Downloads (Pure) -
Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney Disease
Gregorich, M., Kammer, M., Heinzel, A., Böger, C., Eckardt, K. U., Heerspink, H. L., Jung, B., Mayer, G., Meiselbach, H., Schmid, M., Schultheiss, U. T., Heinze, G. & Oberbauer, R., 5-apr.-2023, In: Jama network open. 6, 4, 13 blz., E231870.Onderzoeksoutput › Academic › peer review
Open AccessBestand2 Citaten (Scopus)10 Downloads (Pure) -
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update
Navaneethan, S. D., Zoungas, S., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Liew, A., Michos, E. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Craig, J. C., Tunnicliffe, D. J., Tonelli, M., Cheung, M., Earley, A., Rossing, P., & 2 anderen, 1-mrt.-2023, In: Annals of Internal Medicine. 176, 3, blz. 381-387 7 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand5 Citaten (Scopus)
Activiteiten
-
Basis principes in farmacokinetiek van geneesmiddelen en invloed van obesitas
Jasper Stevens (Speaker) & Hiddo Heerspink (Speaker)
29-jan.-2019Activiteit: Professional or public presentation › Professional
-
Asian-Australian Diabetes Meeting
Hiddo Lambers Heerspink (Invited speaker)
24-aug.-2019Activiteit: Academic presentation › Academic
-
European Association for the Study of Diabetes (EASD) Barcelona 2019
Hiddo Lambers Heerspink (Invited speaker)
17-sep.-2019Activiteit: Academic presentation › Academic
-
ASN Kidney week
Hiddo Lambers Heerspink (Speaker)
7-nov.-2019 → 9-nov.-2019Activiteit: Academic presentation › Academic
-
SGLT2 and the kidney
Hiddo Lambers Heerspink (Speaker)
sep.-2018Activiteit: Professional or public presentation › Professional
Datasets
-
Additional file 3 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Puppala, S. (Contributor), de Zeeuw, D. (Contributor), Sourbron, S. (Contributor), Banks, R. E. (Contributor), Lienczewski, C. (Contributor), Papale, M. (Contributor), Metsärinne, K. (Contributor), Andress, D. (Contributor), Gomez, M. F. (Contributor), Kretzler, M. (Contributor), Tobin, K. (Contributor), Garcia Hernandez, A. (Contributor), Shore, A. C. (Contributor), Gilmour, P. S. (Contributor), Saunavaara, V. (Contributor), Lambers Heerspink, H. (Contributor), Teh, I. (Contributor), Gesualdo, L. (Contributor), Ibberson, M. (Contributor), Shelley, D. (Contributor), Koivuviita, N. (Contributor), Pontrelli, P. (Contributor), Grenier, N. (Contributor), Karihaloo, A. (Contributor), Nuutila, P. (Contributor), Dutius Andersson, A. (Contributor), Welberry Smith, M. (Contributor), Mansfield, M. (Contributor), Sharma, K. (Contributor), Gooding, K. M. (Contributor), Ball, C. (Contributor), Bailey, J. (Contributor), Gilchrist, M. (Contributor), Zetterqvist, A. (Contributor) & Maziarz, M. (Contributor), University of Groningen, 29-jun.-2020
DOI: 10.6084/m9.figshare.12586634.v1
Dataset
-
Supplementary Material for: Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial
Lam, D. (Contributor), Nadkarni, G. N. (Contributor), Mosoyan, G. (Contributor), Neal, B. (Contributor), Mahaffey, K. W. (Contributor), Rosenthal, N. (Contributor), Hansen, M. K. (Contributor), Lambers Heerspink, H. (Contributor), Fleming, F. (Contributor) & Coca, S. G. (Contributor), figshare Academic Research System, 11-jan.-2022
DOI: 10.6084/m9.figshare.18133754.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Clinical_Utility_of_KidneyIntelX_in_Early_Stages_of_Diabetic_Kidney_Disease_in_the_CANVAS_Trial/18133754/1
Dataset
-
Dataset for: Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease
Tighiouart, H. (Contributor), Vonesh, E. (Contributor), Lambers Heerspink, H. (Contributor), Staplin, N. (Contributor), Lewis, J. (Contributor), Inker, L. (Contributor), Ying, J. (Contributor) & Greene, T. (Contributor), University of Groningen, 31-jul.-2019
DOI: 10.6084/m9.figshare.8214638.v1
Dataset
-
Supplementary Material for: Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
Chin, M. P. (Contributor), Bakris, G. L. (Contributor), Block, G. A. (Contributor), Chertow, G. M. (Contributor), Goldsberry, A. (Contributor), Inker, L. A. (Contributor), Lambers Heerspink, H. (Contributor), O'Grady, M. (Contributor), Pergola, P. E. (Contributor), Wanner, C. (Contributor), Warnock, D. G. (Contributor) & Meyer, C. J. (Contributor), University of Groningen, 18-jan.-2018
DOI: 10.6084/m9.figshare.5798001.v1
Dataset
-
Supplementary Material for: The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Levin, A. (Contributor), Greene, T. (Contributor), de Zeeuw, D. (Contributor), Edwards, R. (Contributor), Pollock, C. (Contributor), Zhang, H. (Contributor), Lambers Heerspink, H. (Contributor), Bakris, G. L. (Contributor), Desai, M. (Contributor), Agarwal, R. (Contributor), Neal, B. (Contributor), Jardine, M. J. (Contributor), Zinman, B. (Contributor), Cannon, C. P. (Contributor), Perkovic, V. (Contributor), Bull, S. (Contributor), Brenner, B. M. (Contributor), Mahaffey, K. W. (Contributor), Wheeler, D. C. (Contributor), Charytan, D. M. (Contributor) & Xie, J. (Contributor), University of Groningen, 13-dec.-2017
DOI: 10.6084/m9.figshare.5696959.v1, https://doi.org/10.6084%2Fm9.figshare.5696959.v1
Dataset
Knipsels
-
A Study to Assess the Effects of Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria
05/10/2022
1 item van Media-aandacht
Pers / media: Onderzoek › Popular
-
Diabetes drug can slow kidney function decline, study finds
05/07/2022
1 item van Media-aandacht
Pers / media: Onderzoek › Academic
-
Dapagliflozin did not reduce risks in patients hospitalized with COVID-19
29/04/2022
1 Mediabijdrage
Pers / media: Expert Comment › Popular
-
SGLT2 Inhibitor Safe for Kidneys in Hospitalized COVID Patients
29/04/2022
1 Mediabijdrage
Pers / media: Expert Comment › Professional
-
Does the Drug Dapagliflozin Benefit Hospitalized Patients with Covid-19?
29/04/2022
2 Mediabijdrages
Pers / media: Expert Comment › Professional